281 related articles for article (PubMed ID: 18936059)
41. Structure of human FIH-1 reveals a unique active site pocket and interaction sites for HIF-1 and von Hippel-Lindau.
Lee C; Kim SJ; Jeong DG; Lee SM; Ryu SE
J Biol Chem; 2003 Feb; 278(9):7558-63. PubMed ID: 12482756
[TBL] [Abstract][Full Text] [Related]
42. Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the beta-carbon of asparagine-803.
McNeill LA; Hewitson KS; Claridge TD; Seibel JF; Horsfall LE; Schofield CJ
Biochem J; 2002 Nov; 367(Pt 3):571-5. PubMed ID: 12215170
[TBL] [Abstract][Full Text] [Related]
43. Disruption of dimerization and substrate phosphorylation inhibit factor inhibiting hypoxia-inducible factor (FIH) activity.
Lancaster DE; McNeill LA; McDonough MA; Aplin RT; Hewitson KS; Pugh CW; Ratcliffe PJ; Schofield CJ
Biochem J; 2004 Nov; 383(Pt. 3):429-37. PubMed ID: 15239670
[TBL] [Abstract][Full Text] [Related]
44. ASB4 is a hydroxylation substrate of FIH and promotes vascular differentiation via an oxygen-dependent mechanism.
Ferguson JE; Wu Y; Smith K; Charles P; Powers K; Wang H; Patterson C
Mol Cell Biol; 2007 Sep; 27(18):6407-19. PubMed ID: 17636018
[TBL] [Abstract][Full Text] [Related]
45. Biochemical characterization of human HIF hydroxylases using HIF protein substrates that contain all three hydroxylation sites.
Pappalardi MB; McNulty DE; Martin JD; Fisher KE; Jiang Y; Burns MC; Zhao H; Ho T; Sweitzer S; Schwartz B; Annan RS; Copeland RA; Tummino PJ; Luo L
Biochem J; 2011 Jun; 436(2):363-9. PubMed ID: 21410436
[TBL] [Abstract][Full Text] [Related]
46. Monoclonal antibody-based screening assay for factor inhibiting hypoxia-inducible factor inhibitors.
Lee SH; Jeong Hee Moon ; Eun Ah Cho ; Ryu SE; Myung Kyu Lee
J Biomol Screen; 2008 Jul; 13(6):494-503. PubMed ID: 18566480
[TBL] [Abstract][Full Text] [Related]
47. The facial triad in the α-ketoglutarate dependent oxygenase FIH: A role for sterics in linking substrate binding to O
Hangasky JA; Taabazuing CY; Martin CB; Eron SJ; Knapp MJ
J Inorg Biochem; 2017 Jan; 166():26-33. PubMed ID: 27815979
[TBL] [Abstract][Full Text] [Related]
48. FIH Regulates Cellular Metabolism through Hydroxylation of the Deubiquitinase OTUB1.
Scholz CC; Rodriguez J; Pickel C; Burr S; Fabrizio JA; Nolan KA; Spielmann P; Cavadas MA; Crifo B; Halligan DN; Nathan JA; Peet DJ; Wenger RH; Von Kriegsheim A; Cummins EP; Taylor CT
PLoS Biol; 2016 Jan; 14(1):e1002347. PubMed ID: 26752685
[TBL] [Abstract][Full Text] [Related]
49. FIH Is an Oxygen Sensor in Ovarian Cancer for G9a/GLP-Driven Epigenetic Regulation of Metastasis-Related Genes.
Kang J; Shin SH; Yoon H; Huh J; Shin HW; Chun YS; Park JW
Cancer Res; 2018 Mar; 78(5):1184-1199. PubMed ID: 29259012
[TBL] [Abstract][Full Text] [Related]
50. The FIH hydroxylase is a cellular peroxide sensor that modulates HIF transcriptional activity.
Masson N; Singleton RS; Sekirnik R; Trudgian DC; Ambrose LJ; Miranda MX; Tian YM; Kessler BM; Schofield CJ; Ratcliffe PJ
EMBO Rep; 2012 Mar; 13(3):251-7. PubMed ID: 22310300
[TBL] [Abstract][Full Text] [Related]
51. The Asparagine Hydroxylase FIH: A Unique Oxygen Sensor.
Volkova YL; Pickel C; Jucht AE; Wenger RH; Scholz CC
Antioxid Redox Signal; 2022 Nov; 37(13-15):913-935. PubMed ID: 35166119
[No Abstract] [Full Text] [Related]
52. Prolyl hydroxylase domain protein 3 and asparaginyl hydroxylase factor inhibiting HIF-1 levels are predictive of tumoral behavior and prognosis in hepatocellular carcinoma.
Ma M; Hua S; Li G; Wang S; Cheng X; He S; Wu P; Chen X
Oncotarget; 2017 Feb; 8(8):12983-13002. PubMed ID: 28099905
[TBL] [Abstract][Full Text] [Related]
53. Biochemistry of the hypoxia-inducible factor hydroxylases.
Fiorini G; Schofield CJ
Curr Opin Chem Biol; 2024 Apr; 79():102428. PubMed ID: 38330792
[TBL] [Abstract][Full Text] [Related]
54. Inverse solvent isotope effects arising from substrate triggering in the factor inhibiting hypoxia inducible factor.
Hangasky JA; Saban E; Knapp MJ
Biochemistry; 2013 Mar; 52(9):1594-602. PubMed ID: 23351038
[TBL] [Abstract][Full Text] [Related]
55. Protein Flexibility of the α-Ketoglutarate-Dependent Oxygenase Factor-Inhibiting HIF-1: Implications for Substrate Binding, Catalysis, and Regulation.
Martin CB; Chaplin VD; Eyles SJ; Knapp MJ
Biochemistry; 2019 Oct; 58(39):4047-4057. PubMed ID: 31499004
[TBL] [Abstract][Full Text] [Related]
56. Auto-hydroxylation of FIH-1: an Fe(ii), alpha-ketoglutarate-dependent human hypoxia sensor.
Chen YH; Comeaux LM; Eyles SJ; Knapp MJ
Chem Commun (Camb); 2008 Oct; (39):4768-70. PubMed ID: 18830487
[TBL] [Abstract][Full Text] [Related]
57. Uncoupled O2-activation in the human HIF-asparaginyl hydroxylase, FIH, does not produce reactive oxygen species.
Saban E; Flagg SC; Knapp MJ
J Inorg Biochem; 2011 May; 105(5):630-6. PubMed ID: 21443853
[TBL] [Abstract][Full Text] [Related]
58. Evidence that two enzyme-derived histidine ligands are sufficient for iron binding and catalysis by factor inhibiting HIF (FIH).
Hewitson KS; Holmes SL; Ehrismann D; Hardy AP; Chowdhury R; Schofield CJ; McDonough MA
J Biol Chem; 2008 Sep; 283(38):25971-8. PubMed ID: 18611856
[TBL] [Abstract][Full Text] [Related]
59. A novel mode of action of YC-1 in HIF inhibition: stimulation of FIH-dependent p300 dissociation from HIF-1{alpha}.
Li SH; Shin DH; Chun YS; Lee MK; Kim MS; Park JW
Mol Cancer Ther; 2008 Dec; 7(12):3729-38. PubMed ID: 19074848
[TBL] [Abstract][Full Text] [Related]
60. Evolution of hypoxia and hypoxia-inducible factor asparaginyl hydroxylase regulation in chronic kidney disease.
Faivre A; Dissard R; Kuo W; Verissimo T; Legouis D; Arnoux G; Heckenmeyer C; Fernandez M; Tihy M; Rajaram RD; Delitsikou V; Le NA; Spingler B; Mueller B; Shulz G; Lindenmeyer M; Cohen C; Rutkowski JM; Moll S; Scholz CC; Kurtcuoglu V; de Seigneux S
Nephrol Dial Transplant; 2023 Sep; 38(10):2276-2288. PubMed ID: 37096392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
